OurCrowd
AUGUST 13, 2020
Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, Read more here. DarioHealth Corp.
TechCrunch
OCTOBER 18, 2021
In October, Limbix, a company creating digital therapeutics for adolescents, released data from a trial on its new product: SparkRx. In the study, 160 adolescents aged 13-22 were assigned to use SparkRx or another app providing mental health education. SparkRx is a self-guided therapy program for teens run entirely on a phone.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
OurCrowd
MAY 13, 2020
BOSTON, May 13, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, today announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services. Read more here.
OurCrowd
AUGUST 11, 2019
(NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators (“AADE”) conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in (..)
OurCrowd
JUNE 14, 2020
Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services. Read more here.
TechCrunch
JULY 11, 2022
D’Ambra and Zhang previously worked in digital health spaces before deciding to found Arise, a New York–based virtual eating disorder care company. Arise is looking to provide education, care and long-term support from licensed providers and personalized care plans for those afflicted with any disordered eating.
TechCrunch
MAY 12, 2023
Our overall focus is and has always been on central nervous system (CNS), and we are agnostic as to the modality, be it psychedelic drug development, other pharmacological approaches, medtech devices, or digital therapeutics. Additionally, a reliable source of information to educate individuals would be required.
Expert insights. Personalized for you.
36 
Let's personalize your content